Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarks Electric Share News (MRK)

Share Price Information for Marks Electric (MRK)

Share Price is delayed by 15 minutes
Get Live Data
45.50    -3.50 (-7.14%)
Bid:
45.00
Ask:
46.00
Spread: 1.00 (2.222%)
Market Cap: £47.44m
MRK Live PriceLast checked at - London Stock Exchange

Intraday Marks Electric Share Chart

Marks Electric News

Reuters Health News Summary
27 Mar 2018

Reuters Health News Summary

Following is a summary of current health news briefs. Severely elevated cholesterol often goes untreated Many patients with dangerously high cholester...

Reuters Health News Summary
26 Mar 2018

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical ...

Reuters Health News Summary
26 Mar 2018

Reuters Health News Summary

Following is a summary of current health news briefs. Biohaven plunges as investors pit migraine data against Allergan's drug Biohaven Pharmaceutical ...

Reuters Health News Summary
26 Mar 2018

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

Reuters Health News Summary
26 Mar 2018

Reuters Health News Summary

Following is a summary of current health news briefs. Singapore pharma on recovery path after worst output in decades Singapore's among

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success
26 Mar 2018

UPDATE 1-Roche's Tecentriq cocktail notches another lung cancer success

ZURICH, March 26 (Reuters) - Roche's immunotherapy Tecentriq combined with other drugs boosted lung cancer patients' survival versus an older cocktail...

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division
21 Mar 2018

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets * Pharma head says commercial revamp matches R&D changes * Cancer a big pipeline focus, pro...

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer
20 Mar 2018

UPDATE 1-Roche says Tecentriq, chemo cut risk of death in type of lung cancer

ZURICH, March 20 (Reuters) - Roche's immunotherapy Tecentriq plus chemotherapy cut the risk of disease worsening or death in advanced squamous lung ca...